Research Article: Granulomatous lobular mastitis in pregnancy: report of 29 cases
Abstract:
Granulomatous lobular mastitis (GLM) is a rare inflammatory breast disease, and there are few reports of GLM in pregnancy (GLMIP). Therefore, this study retrospectively analyzed cases diagnosed with GLMIP from 2011 to 2023 and found that in patients with GLMIP there were varied demographic manifestations such as age, pregnancy weeks, and numbers of pregnancy and delivery, and several associated complications including erythema nodosum, arthritis and lower extremity edema. Among them, 82.8% of the patients received integrated traditional Chinese medicine (TCM) and western medicine treatment, and 17.2% of the patients received TCM treatment alone, but the application rate of TCM treatment was 100%. The results showed that both groups significantly improved the effective rate (91.7% and 60.0%, respectively), improved breast appearance (4.1% and 20.0%, respectively), reduced the rate of progression or recurrence rate (8.3% and 60.0%, respectively), and shortened the time for complete remission (13.793 months vs 12.625 months, respectively). To date this study is the one with the largest sample size of GLMIP, but also the one with the largest sample size in which the combination of TCM treatment and non-surgical treatment was applied. The complications include erythema nodosum, arthritis and lower extremity edema. Therefore, the application of TCM in the treatment of GLMIP is worth promoting vigorously.
Introduction:
Granulomatous lobular mastitis (GLM), also known as idiopathic granulomatous mastitis, is a chronic inflammatory disease, with granuloma formation in the breast tissues being the major pathological feature ( 1 ). GLM was first reported in 1972 by Kessler et al. ( 2 ). GLM usually occurs in women of childbearing age, but the onset during pregnancy is extremely rare ( 3 ). According to clinical reports, the incidence of GLM in pregnancy (GLMIP) is less than 5.66% ( 4 ). However, the incidence of GLMIP has gradually…
Read more